|
aap Implantate AG / Key word(s): Miscellaneous aap Implantate AG: Possible cyber attack on aap 15-Oct-2024 / 23:25 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. aap Implantate AG (the “Company”) determined that there may have been a cyber attack on the Company’s IT systems. In response, the Company proactively disconnected the systems from the internet to prevent data breaches and data corruption. The IT systems and the extent of the impact are currently being reviewed. In doing so, the utmost care is being taken to ensure data integrity. Contact: aap Implantate AG; R. Di Girolamo; Chairman of the Management Board / CEO; Lorenzweg 5; D-12099 Berlin Tel.: +49/30/750 19 – 170; Fax: +49/30/750 19 – 290; r.digirolamo@aap.de End of Inside Information 15-Oct-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Cryobiopsy and Forceps Biopsy Go Head-to-Head for Diagnosing Lung Lesions
As a supplement to standard needle aspiration for diagnosing lung lesions, cryobiopsy was no better than forceps biopsy for producing a definite diagnosis in a
January 10, 2024